NHS Weight Loss Injections: Eligibility and Access Guide

The NHS has finally made powerful weight-loss injections available—yet strict eligibility rules mean most patients still cannot access them. This guide walks through everything the NHS officially offers, what the BMI and condition thresholds actually mean, and how the referral process works so you can have a concrete conversation with your GP.

Approved Injections: Tirzepatide (Mounjaro), semaglutide (Wegovy), liraglutide (Saxenda) ·
BMI Requirement: At least 40 ·
Additional Criteria: At least 4 of 5 weight-related conditions ·
How They Work: Reduce hunger, promote fullness ·
UK Availability: NHS prescription via GP referral

These key facts establish the current state of NHS injectable weight-loss medicines in England.

Can I get Mounjaro on the NHS for weight loss?

Yes—Mounjaro (the brand name for tirzepatide) became available through NHS GPs from 23 June 2025 as part of a phased 12-year rollout plan, with eligibility currently prioritising patients who have the highest clinical need ( Asda Online Doctor ).

Eligibility criteria for Mounjaro

To receive Mounjaro on the NHS, you must meet two sets of requirements. First, your BMI must be 40 or above, or 37.5 or above if you are from a Black African, African-Caribbean, Asian, Chinese, or Middle Eastern background. Second, you need to have at least four of five specific weight-related health conditions: type 2 diabetes, high blood pressure, heart disease, obstructive sleep apnoea, or high cholesterol ( NHS.uk ).

As of December 2025, participation in wraparound support—including diet coaching and exercise programmes—has become mandatory for all NHS Mounjaro patients. If you do not engage with this support, your prescription will be stopped. The NHS is targeting around 250,000 patients over the 2025–2028 period, prioritising those with the most severe obesity-related complications ( Which? ).

Referral process

Mounjaro differs from older weight-loss injections because some GPs can prescribe it directly once local Integrated Care Boards (ICBs) have signed them up to the programme. Not every GP surgery participates yet—availability depends on your local ICB’s rollout decisions. Check your local ICB website to find out whether Mounjaro is available through GPs in your area ( Asda Online Doctor ).

Is Ozempic available on the NHS for weight loss?

Ozempic is not currently prescribed on the NHS specifically for weight loss. Its licence in the UK covers only the treatment of type 2 diabetes, which means patients seeking weight-loss support through the NHS cannot access Ozempic for that purpose ( Superdrug Online Doctor ).

Differences from Wegovy

Wegovy and Ozempic both contain the active ingredient semaglutide, but they are different products with different licences and doses. Wegovy is licensed specifically for weight management and is available on the NHS for eligible patients. Ozempic is licensed for blood sugar control in type 2 diabetes and, while weight loss is a common side effect, it cannot be prescribed on the NHS solely for that purpose ( Asda Online Doctor ).

NHS approval status

Wegovy received NHS approval through NICE guidance and launched in the UK on 4 September 2023, with NHS availability mandated within three months of commercial launch ( NHS Health Media Blog ). Unlike Mounjaro, Wegovy requires referral to a tier 3 specialist weight management service—a referral your GP cannot bypass.

What is Wegovy on the NHS?

Wegovy is the brand name for semaglutide, a weekly injection designed to reduce appetite and help patients feel fuller for longer. NICE recommends that Wegovy should be prescribed alongside diet and physical activity support to maximise its effectiveness ( NHS Health Media Blog ).

How Wegovy works

Wegovy mimics a hormone called GLP-1 that the gut releases after eating, signalling to the brain that you are full. This reduces hunger pangs and makes it easier to eat smaller portions without the constant feeling of deprivation that often derails weight-loss efforts. Clinical trials showed participants losing an average of around 15% of their body weight when combined with lifestyle support ( Superdrug Online Doctor ).

Access via specialist services

Unlike Mounjaro, your GP cannot prescribe Wegovy directly. You need a referral to a tier 3 specialist weight management service, which assesses your eligibility and manages your treatment. On the NHS, Wegovy treatment is limited to a maximum of two years, with a review after six months—if you have not lost at least 5% of your body weight by that point, treatment is typically stopped ( Asda Online Doctor ).

The pattern here is important: Wegovy access is gatekept by specialist services that many patients wait months or even years to reach. Regional variation in tier 3 service availability is significant, and long waits are common ( Asda Online Doctor ).

What is the GP weight loss referral scheme?

The GP referral scheme is the pathway through which patients access NHS specialist weight management services, including the injectable medications Wegovy and Saxenda. Your GP acts as the gateway, assessing your eligibility and sending a referral to a tier 3 service if you qualify ( Superdrug Online Doctor ).

Referral steps

The process begins with a conversation at your GP surgery. Your doctor will check your BMI, review any weight-related health conditions you have, and assess whether a specialist referral is appropriate. If you meet the criteria, they will refer you to your local tier 3 weight management service. From there, the specialist team determines which treatment, if any, is suitable for you ( NHS.uk ).

Tier 3 and Tier 4 services

Tier 3 services are specialist weight management teams typically based in hospitals or community clinics, staffed by dietitians, specialist nurses, psychologists, and bariatric physicians. Tier 4 refers to surgical options such as gastric bands or bypasses—usually reserved for patients with severe obesity and significant health complications. Wegovy and Saxenda sit within the tier 3 framework, while Mounjaro currently offers a more accessible route via some GPs for the highest-need patients ( NHS England ).

Who qualifies for weight loss injections on the NHS?

Eligibility depends on which medication you are considering, and the thresholds differ significantly between Mounjaro, Wegovy, and Saxenda. The common thread is that all three require a substantial BMI and at least one weight-related health condition—but the exact requirements vary ( NHS England ).

BMI and condition requirements

For Mounjaro through your GP, you need a BMI of 40 or above (37.5 or above for certain ethnic backgrounds) plus at least four of five specified conditions. For Wegovy through tier 3, a BMI of 35 or above (32.5 for certain ethnic backgrounds) with at least one weight-related health problem is the baseline, though specialist services can accept patients with a BMI as low as 30 if they meet additional clinical criteria. Saxenda requires a BMI of 35 or above (32.5 for certain ethnic groups), non-diabetic hyperglycaemia or high cardiovascular disease risk, and patients must be under 75 years old ( Asda Online Doctor ).

What this means in practice: the lower your BMI and the fewer conditions you have, the harder it becomes to access NHS injections. Mounjaro has the strictest entry threshold initially, but that threshold is planned to lower progressively—June 2026 should bring eligibility for BMI 35+ with four conditions, and April 2027 for BMI 40+ with three conditions ( Asda Online Doctor ).

Available injections overview

Three GLP-1 receptor agonist injections are currently available on the NHS in England. Mounjaro (tirzepatide) works by targeting two hormone receptors instead of one, producing a stronger appetite-suppressing effect than single-receptor drugs. Wegovy (semaglutide) and Saxenda (liraglutide) target the GLP-1 receptor alone and have been available through specialist services for longer. Saxenda requires a daily injection, whereas both Mounjaro and Wegovy are weekly injections ( Superdrug Online Doctor ). For those seeking more information on NHS weight loss injections, you can find details at $how to get rid of headaches.

Comparison of NHS Weight Loss Injections

Three medications, three very different access routes and clinical profiles.

This comparison reveals how Mounjaro offers the most direct NHS access route, but with the strictest initial eligibility, while Wegovy and Saxenda require specialist referral despite lower BMI thresholds.

Detailed Specifications

Six key specifications that determine which medication you might qualify for.

This specification table shows how eligibility requirements escalate in complexity beyond simple BMI thresholds.

How to Get a Weight Loss Injection on the NHS

Five steps from checking your eligibility to starting treatment.

1. Check your BMI and conditions. Calculate your BMI and identify any weight-related health conditions you have (type 2 diabetes, high blood pressure, heart disease, sleep apnoea, or high cholesterol). Use the NHS BMI calculator and note your results to take to your GP.
2. Book a GP appointment. Ask for a longer appointment if possible, as these conversations can take time. Bring a note of your BMI, existing conditions, and any previous weight-loss attempts to share with your doctor.
3. Ask about a referral. If your GP agrees a referral is appropriate, they will send a referral to your local tier 3 specialist weight management service. For Mounjaro, ask whether your GP practice is enrolled in the local ICB programme.
4. Attend your specialist assessment. The tier 3 team will assess your full medical history, confirm your eligibility, and discuss which medication, if any, is suitable. For Mounjaro, this step may be handled directly by your GP if they are enrolled.
5. Start treatment and engage with support. Once prescribed, attend all coaching and monitoring appointments. From December 2025, non-engagement with the mandatory wraparound support programme results in prescription stoppage ( Which? ).

The new weight management medication, ‘Tirzepatide’ (brand name Mounjaro®) is being made available to NHS patients to support weight loss.

— South Yorkshire ICB, NHS Integrated Care Board ( South Yorkshire ICB )

NICE recommend that Wegovy should be prescribed alongside diet and physical activity support.

— NHS Health Media Blog ( NHS Health Media Blog )

Under a phased 12-year rollout plan which started in June 2025, the NHS is currently prioritising Mounjaro for those with the highest clinical risk.

— Which?, Consumer Champion ( Which? )

Related reading: Symptoms of Stomach Cancer · Is Coffee Good for You

Access to Mounjaro and Wegovy follows the eligibility criteria, requiring BMI ≥40 or comorbidities plus GP referral in England.

Frequently asked questions